# Application of Nanotechnology and Chemical Sensors for Diagnosis of Decompensated Heart Failure by Respiratory Samples

> **NCT03083717** · — · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 150 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DIAGNOSTIC_TEST:** Collection of breath samples, followed by analysis of exhaled breath using nanomaterial-based sensors (NaNose)

## Key facts

- **NCT ID:** NCT03083717
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-20
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03083717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03083717, "Application of Nanotechnology and Chemical Sensors for Diagnosis of Decompensated Heart Failure by Respiratory Samples". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03083717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*